CAPITA

CAPiTA is the largest vaccine trial worldwide conducted to date in older adults. Its primary objective was to establish the efficacy of a 13-valent pneumococcal vaccine in preventing a first episode of vaccine serotype-specific pneumococcal community-acquired pneumonia (CAP).